GlassScriptPhysician profile
Vamsi Krishna Kunam
NPI 1942516521
$3,800.27
in general payments reported to CMS, 2019-2025
8 companies · $1,091 in 2025
The $1,091 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,266 · 2021: $221 · 2022: $108 · 2023: $778 · 2024: $337 · 2025: $1,091.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,553 · Food and Beverage: $653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,553.18 |
| Food and Beverage | $652.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $1,265.87 | 2020 | |
| Sirtex Medical INC | $1,111.42 | 2024-2025 | Lava Les (Liquid Embolic System), Sir-Spheres Microspheres |
| Inari Medical, INC. | $886.35 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $187.69 | 2021-2022 | |
| Penumbra, INC. | $170.14 | 2022-2024 | Penumbra System |
| W. L. Gore & Associates, INC. | $139.40 | 2021-2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Ethicon US, LLC | $21.87 | 2021 | |
| Becton, Dickinson and Company | $17.53 | 2024 | Lifestream |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vamsi Kunam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.